Drug-Induced Uveitis Related to Checkpoint Inhibitors and MAP-kinase Inhibitors-Reference-Cited by-同舟云学术

Drug-Induced Uveitis Related to Checkpoint Inhibitors and MAP-kinase Inhibitors

Published:2024-02 Issue:2 Volume:131 Page:249-251
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Thibault Thomas^ORCID,Ben Ghezala Inès,Freppel Romane,Rajillah Abdessamad,Boulay Charlène,Brunel Pierre,Atzenhoffer Marina,Auvens Clément,Devilliers Hervé,Grandvuillemin Aurélie

Publisher

Elsevier BV

Subject

Ophthalmology

Reference7 articles.

1. Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO’s pharmacovigilance database;Anquetil;J Autoimmun,2020

2. Immune checkpoint inhibitor-associated uveitis: review of treatments and outcomes;Dow;Ocul Immunol Inflamm,2021

3. Ocular safety profile of BRAF and MEK inhibitors: data from the World Health Organization Pharmacovigilance Database;Mettler;Ophthalmology,2021

4. Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis;Dick;Ophthalmology,2016

5. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop;Jabs;Am J Ophthalmol,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VKH-like uveitis during donafenib therapy for hepatocellular carcinoma: a case report and review of the literature;Frontiers in Pharmacology;2024-07-18

2. Incident Noninfectious Uveitis Risk after Immune Checkpoint Inhibitor Treatment;Ophthalmology;2024-07

3. Re: Thibault et al.: Drug-induced uveitis related to checkpoint inhibitors and MAP-kinase inhibitors (Ophthalmology. 2024;131:249–251);Ophthalmology;2024-07

4. Reply;Ophthalmology;2024-07